Chemotherapy for breast and lung cancer: 30-day mortality
A companion report to the Lancet Oncology paper, providing trust-level analyses.
Documents
Details
This cancer report is co-authored by PHE’s National Cancer Registration and Analysis Service and Cancer Research UK and is the first major report using world-first systemic anticancer treatment (SACT) data.
NHS hospital trusts began submitting data in April 2012, and submission became mandatory for all NHS hospital trusts in England from April 2014.
The data gives new, trust-level insights about the real-world chemotherapy treatment of patients in the NHS in England which was previously only available from clinical trials.